News
Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...
Hosted on MSN17d
GSK buys US-based rare cancer treatment developer for up to £1bnaccording to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...
British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action ...
In its 2024 Global Cancer Statistics report, the American Cancer Society has brought attention ... plan that includes ...
The results were featured at the American Society of Haematology (ASH) annual meeting and, according to GSK, "support the potential ... treatment for the blood cancer. After being all but written ...
GSK isn't revealing the size of the OS improvement yet – it has promised to do so at the American Society for Haematology ... At this year's ASCO cancer congress in February, earlier results ...
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results